DnB Asset Management
PRCT icon

DnB Asset Management’s Procept Biorobotics PRCT Stock Holding History

DnB Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,151
Closed -$1.18M – 1335
2026
Q1 		$1.18M Sell
47,151
-52,416
-53% -$1.48M ﹤0.01% 630
2025
Q4 		$3.13M Buy
99,567
+67,848
+214% +$2.25M 0.01% 538
2025
Q3 		$1.13M Buy
+31,719
New +$1.45M ﹤0.01% 627

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

DnB Asset Management's PRCT Position: Q2 2026 in Review

DnB Asset Management sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 47,151 shares — an estimated $1.18M sold.

DnB Asset Management first reported a position in PRCT in Q3 2025 and held it in 3 quarters. The position peaked at $3.13M in Q4 2025. 144 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • DnB Asset Management reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • DnB Asset Management sold 47,151 Procept Biorobotics shares in Q2 2026, an estimated $1.18M.
  • DnB Asset Management first reported a position in Procept Biorobotics in Q3 2025 and held it in 3 quarters.
  • DnB Asset Management's Procept Biorobotics position peaked at $3.13M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.